A capillary zone electrophoresis method to investigate the oligomerization of the human Islet Amyloid Polypeptide involved in Type 2 Diabetes
Abstract
Type 2 diabetes is characterized by the aggregation of human Islet Amyloid Polypeptide (hIAPP) from monomer to large and insoluble fibrils. According to several recent studies, small soluble oligomers are now considered as potential toxic species. No monitoring tool has been to date reported to mimic in vitro the oligomerization process of hIAPP over time, although this would allow selecting candidate compounds that slow down or stop this pathological process. Considering the poor stability of those species and the necessity to monitor in real time, a compatible with the monitoring of hIAPP oligomerization CE method coupled to UV detection was developed. Three groups of hIAPP oligomers/monomers formed during this process could be separated. A polybrene coating was used to avoid adsorption of hIAPP onto capillary walls. Peaks identification was performed using a combination of CE-MS, filtrations and SDS-PAGE. They revealed that one peak is composed of monomer with a very small amount of dimer and trimer, whereas the two others are composed of bigger species higher than 100 kDa. We demonstrated that this real time oligomerization process started from the very initial step, with hIAPP principally as a monomer, until the formation of very big oligomers. This method was shown to be repeatable with RSDs on electrophoretic mobilities and relative peak areas less than 1.6 and 5.8% respectively for the monomer peak. Its application to study the anti-aggregation properties of resveratrol showed that this compound saved more than 30% of the monomeric hIAPP form whereas it almost disappeared without. The method opens new perspectives for the screening of potential drugs for type 2 diabetes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697 · see citing works
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · see citing works
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
Biancalana, M., & Koide, S. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.04.001 · Cited by 2,203 · see citing works
Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management
Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00006 · Cited by 1,500 · see citing works
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044 · see citing works
Mechanism of thioflavin T binding to amyloid fibrils
Khurana, R., Coleman, C., Ionescu‐Zanetti, C., Carter, S. A., Krishna, V., Grover, R. K., Roy, R., & Singh, S. S. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.06.006 · Cited by 833 · see citing works
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612 · see citing works
Type 2 diabetes as a protein misfolding disease
Mukherjee, A., Morales‐Scheihing, D., Butler, P. C., & Soto, C. A. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.04.005 · Cited by 338 · see citing works
Young, L. M., Saunders, J. C., Mahood, R. A., Revill, C., Foster, R. J., Tu, L., Raleigh, D. P., Radford, S. E., & Ashcroft, A. E. (2014) · Nature Chemistry · doi:10.1038/nchem.2129 · Cited by 281 · see citing works
Islet amyloid polypeptide: structure, function, and pathophysiology
Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2798269 · Cited by 273 · see citing works
Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease
Li, F., Gong, Q., Dong, H., & Shi, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919075 · Cited by 231 · see citing works
Chapter 20 Protein Precipitation Techniques
Burgess, R. R. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)63020-2 · Cited by 223 · see citing works
Mechanisms of islet amyloidosis toxicity in type 2 diabetes
Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 201 · see citing works
Young, L. M., Cao, P., Raleigh, D. P., Ashcroft, A. E., & Radford, S. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406831n · Cited by 190 · see citing works
Glucagon-like peptide-1 analogues: An overview
Gupta, V. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.111625 · Cited by 186 · see citing works
Insulin therapy for type 2 diabetes.
Swinnen, S. G., Hoekstra, J. B., & DeVries, J. H. (2009) · Diabetes Care · doi:10.2337/dc09-s318 · Cited by 181 · see citing works
Marek, P., Patsalo, V., Green, D. F., & Raleigh, D. P. (2012) · Biochemistry · doi:10.1021/bi300574r · Cited by 168 · see citing works
Erim, F. B., Cifuentes, A., Poppe, H., et al. (1995) · Journal of Chromatography A · doi:10.1016/0021-9673(95)00394-3 · Cited by 158 · see citing works
Structural Characterisation of Islet Amyloid Polypeptide Fibrils
Makin, O. S., & Serpell, L. C. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.048 · Cited by 147 · see citing works
Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives
Pithadia, A. S., Brender, J., Fierke, C. A., & Ramamoorthy, A. (2015) · Journal of Diabetes Research · doi:10.1155/2016/2046327 · Cited by 142 · see citing works
Hilton, G. R., & Benesch, J. L. P. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0823 · Cited by 140 · see citing works
Fibril Structure of Human Islet Amyloid Polypeptide*♦
Bedrood, S., Li, Y.-Y., Isas, J., Hegde, B. G., Baxa, U., Haworth, I., & Langen, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327817 · Cited by 136 · see citing works
The β-cell assassin: IAPP cytotoxicity
Raleigh, D. P., Zhang, X., Hastoy, B., & Clark, A. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0105 · Cited by 135 · see citing works
Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
Haas, B., Eckstein, N., Pfeifer, V., Mayer, P. E., & Hass, M. D. S. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.40 · Cited by 114 · see citing works
pH Dependence of Amylin Fibrillization
Jha, S., Snell, J. M., Sheftic, S. R., Patil, S. M., Daniels, S. B., Kolling, F. W., & Alexandrescu, A. T. (2013) · Biochemistry · doi:10.1021/bi401164k · Cited by 112 · see citing works
The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide*
Wei, L., Jiang, P., Xu, W., Li, H., Zhang, H., Yan, L., Chan-Park, M., Liu, X.-W., Tang, K., Mu, Y., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166678 · Cited by 105 · see citing works
Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes
Pillay, K., & Govender, P. (2013) · BioMed Research International · doi:10.1155/2013/826706 · Cited by 94 · see citing works
Bram, Y., Frydman‐Marom, A., Yanai, I., Gilead, S., Shaltiel‐Karyo, R., Amdursky, N., & Gazit, E. (2014) · Scientific Reports · doi:10.1038/srep04267 · Cited by 89 · see citing works
Low pH acts as inhibitor of membrane damage induced by human islet amyloid polypeptide.
Khemtemourian, L., Doménech, E., Doux, J. P. F., Koorengevel, M., & Killian, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja205007j · Cited by 83 · see citing works
Susa, A. C., Wu, C. F., Bernstein, S. L., Dupuis, N., Wang, H., Raleigh, D. P., Shea, J., & Bowers, M. T. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504031d · Cited by 76 · see citing works
Capillary electrophoresis studies on the aggregation process of β‐amyloid 1‐42 and 1‐40 peptides
Sabella, S., Quaglia, M., Lanni, C., Racchi, M., Govoni, S. M., Caccialanza, G., Calligaro, A., Bellotti, V., & Lorenzi, E. D. (2004) · Electrophoresis · doi:10.1002/elps.200406062 · Cited by 73 · see citing works
Sebastiao, M., Quittot, N., & Bourgault, S. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.06.007 · Cited by 72 · see citing works
ESI-IMS–MS: A method for rapid analysis of protein aggregation and its inhibition by small molecules
Young, L. M., Saunders, J. C., Mahood, R. A., Revill, C., Foster, R. J., Ashcroft, A. E., & Radford, S. E. (2015) · Methods · doi:10.1016/j.ymeth.2015.05.017 · Cited by 66 · see citing works
Tu, L., Young, L. M., Wong, A. G., Ashcroft, A. E., Radford, S. E., & Raleigh, D. P. (2014) · Biochemistry · doi:10.1021/bi501016r · Cited by 61 · see citing works
How Type II Diabetes-Related Islet Amyloid Polypeptide Damages Lipid Bilayers
Lee, C., Sun, Y., & Huang, H. W. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.01.039 · Cited by 61 · see citing works
Haselberg, R., de Jong, G. J., & Somsen, G. W. (2009) · Journal of Separation Science · doi:10.1002/jssc.200900164 · Cited by 56 · see citing works
A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide
Kumar, S., & Miranker, A. D. (2013) · Chemical Communications · doi:10.1039/c3cc41452c · Cited by 52 · see citing works
Andrews, M. N., & Winter, R. (2011) · Biophysical Chemistry · doi:10.1016/j.bpc.2010.12.007 · Cited by 50 · see citing works
Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry
Larson, J. L., Ko, E. C., & Miranker, A. D. (2000) · Protein Science · doi:10.1110/ps.9.2.427 · Cited by 49 · see citing works
Figeys, D., & Aebersold, R. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00022-4 · Cited by 42 · see citing works
Amphiphilic oligoamide α-helix peptidomimetics inhibit islet amyloid polypeptide aggregation
Kulikov, O. V., Kumar, S., Magzoub, M. M., et al. (2015) · Tetrahedron Letters · doi:10.1016/j.tetlet.2015.02.132 · Cited by 40 · see citing works
Folded Small Molecule Manipulation of Islet Amyloid Polypeptide
Kumar, S., Brown, M. A., Nath, A., & Miranker, A. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.05.007 · Cited by 34 · see citing works
Brinet, D., Kaffy, J., Oukacine, F., Glumm, S., Ongeri, S., & Taverna, M. (2014) · Electrophoresis · doi:10.1002/elps.201400271 · Cited by 30 · see citing works
Self-citationStepwise oligomerization of murine amylin and assembly of amyloid fibrils.
Palmieri, L., Melo-Ferreira, B., Braga, C., Fontes, G. N., Mattos, L., & Lima, L. M. T. R. (2013) · Biophysical Chemistry · doi:10.1016/j.bpc.2013.07.013 · Cited by 23 · see citing works
Influence of trehalose on human islet amyloid polypeptide fibrillation and aggregation
Chen, C., Yao, T. S., Zhang, Q., He, Y., Xu, L., Zheng, M., Zhou, G., Zhang, Y., Yang, H., & Zhou, P. (2016) · RSC Advances · doi:10.1039/c5ra27689f · Cited by 23 · see citing works
On the structure of the copper–amylin complex
Riba‐Garcia, I., Barran, P. E., Cooper, G. J. S., & Unwin, R. D. (2015) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2015.09.001 · Cited by 18 · see citing works
Field amplified sample stacking of amyloid beta (1-42) oligomers using capillary electrophoresis
Paracha, S., & Hestekin, C. N. (2016) · Biomicrofluidics · doi:10.1063/1.4954051 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Recent trends of capillary electrophoresis‐mass spectrometry in proteomics research
Gomes, F. P., & Yates, J. R. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21599 · Cited by 112 · see citing works
- Authors
- Berardet, C., Kaffy, J., Ongeri, S., & Taverna, M.
- Affiliations
- Université Paris-Sud (FR)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Taverna, Myriam
- Venue
- Journal of Chromatography A
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 1578
- Pages
- 83-90
- ISSN
- 0021-9673 (ISSN-L)
- OpenAlex
- W2896542353
- Cited by
- 11
- References
- 47
- Citations by year
- 2026: 1 · 2024: 1 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Chromatography A (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-IDEX-0003)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- human islet amyloid polypeptide, type 2 diabetes, amyloid fibril formation, capillary zone electrophoresis, resveratrol, anti-aggregation activity, drug screening, UV detection
- MeSH terms
- Chemistry Techniques, Analytical, Diabetes Mellitus, Type 2, Humans, Electrophoresis, Capillary, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review